Loading insider details...
Latest Form 4 (Feb 20, 2026): Grant/Award of 215,000 TRVI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 215,000 | n/a |
| Feb 20, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 257,500 | n/a |
| Oct 1, 2024 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 400,000 | n/a |
| Jun 14, 2024 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 30,000 | n/a |
| Jun 30, 2023 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 30,000 | n/a |
| Jun 23, 2022 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 20,000 | n/a |
| Jun 17, 2021 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 20,000 | n/a |
| Feb 18, 2020 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 23,684 | n/a |